Pharmakon Advisors
Finance · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
110 E 59th St Fl 33, New York, New York,...Phone Number
(212) 883-2296Website
www.pharmakonadvisors.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
2
2
2
About Pharmakon Advisors
Pharmakon Advisors, LP is an investment management firm that specializes in providing strategic financing solutions to the life sciences industry. The firm has committed over $10 billion across 64 transactions, supporting companies in biotechnology, pharmaceuticals, medical technology, and diagnostics. Its primary clients include entities within the life sciences sector seeking investment and financing opportunities. Pharmakon Advisors serves as the investment manager for the BioPharma Credit Investment funds.Explore more
Pharmakon Advisors Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharmakon Advisors your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Pharmakon Advisors
Funding: Get notified immidiatlly once Pharmakon Advisors has new funding data
Earning: See what the market has to say on Pharmakon Advisors recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Pharmakon Advisors is spiking on competitors!
Check if Pharmakon Advisors has recently received funding, and reach out quickly before it becomes old news!
Pharmakon Advisors, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Pharmakon Advisors launches new products
Click to see if Pharmakon Advisors had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Pharmakon Advisors
Find 3 more new buyers
Compare Similar Companies to Pharmakon Advisors
Compare insights from companies similar to Pharmakon Advisors, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pharmakon Advisors is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Pharmakon Advisors is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Pharmakon Advisors.
Pharmakon Advisors Tech Stack
A closer look at the technologies used by Pharmakon Advisors
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Pharmakon Advisors News & Media
Kestra Medical Secures Up to $200M Non-Dilutive Financing | KMTS Stock News
A portion of the $75M closing tranche retired Kestra’s existing $45M term loan; total liquidity is approximately $357M, with SEC details due today.Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP.Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
Allschwil, Switzerland – June 26, 2026 Idorsia Ltd (SIX: IDIA), a commercial-stage biopharmaceutical company with a portfolio of first- or best-in-class assets, today confirmed the successful closing of its previously announced senior secured term loan agreement of up to CHF 250 million with investment funds managed by Pharmakon Advisors, LP.Goodwin Advises Pharmakon Advisors on Intellectual Property Aspects for CHF 250 Million ...
Goodwin's Intellectual Property team advised Pharmakon Advisors, LP on IP aspects associated with entering into a senior secured term loan agreement of up to CHF 250 million ($310 million USD). Learn more.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmakon Advisors
Sign Up For FreeTo access detailed company insights
Pharmakon Advisors, LP is an investment management firm that specializes in providing strategic financing solutions to the life sciences industry. The firm has committed over $10 billion across 64 transactions, supporting companies in biotechnology, pharmaceuticals, medical technology, and diagnostics. Its primary clients include entities within th... Read More
